Piper Sandler Reiterates Overweight on Edwards Lifesciences, Raises Price Target to $115
Benzinga Newsdesk 8 hours ago
Analyst RatingsNewsReiterationPrice TargetHot
Piper Sandler analyst Adam Maeder reiterates Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $101 to $115.
Piper Sandler analyst Adam Maeder reiterates Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $101 to $115.